These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1697709

  • 1. Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.
    Gallee MP, Visser-de Jong E, van der Korput JA, van der Kwast TH, ten Kate FJ, Schroeder FH, Trapman J.
    Urol Res; 1990; 18(3):181-7. PubMed ID: 1697709
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
    Abrahamsson PA, Lilja H, Falkmer S, Wadström LB.
    Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
    [Abstract] [Full Text] [Related]

  • 4. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG.
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [Abstract] [Full Text] [Related]

  • 5. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM, Schellhammer PF, Brassil DN, Wright GL.
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
    Oesterling JE.
    J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM, Heatfield BM, Trump BF.
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [Abstract] [Full Text] [Related]

  • 10. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A, Ersev D, Turkeri L, Ilker Y, Simsek F, Kullu S, Akdas A.
    Prog Clin Biol Res; 1990 Jan; 357():129-34. PubMed ID: 1699237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.
    Chan TY, Mikolajczyk SD, Lecksell K, Shue MJ, Rittenhouse HG, Partin AW, Epstein JI.
    Urology; 2003 Jul; 62(1):177-81. PubMed ID: 12837462
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostatic specific antigen: immunoreactivity in urachal remnants.
    Golz R, Schubert GE.
    J Urol; 1989 Jun; 141(6):1480-2. PubMed ID: 2470928
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
    Buamah PK, Johnson P, Skillen AW.
    Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical demonstration of tumor-associated antigens in prostatic carcinomas of various histological differentiations.
    Friedmann W, Steffens J, Lobeck H, Blümcke S, Nagel R.
    Eur Urol; 1985 Dec; 11(1):52-6. PubMed ID: 2580711
    [Abstract] [Full Text] [Related]

  • 18. Is prostate-specific antigen the most useful marker for screening in prostate cancer?
    Delaere KP, Van Dieijen-Visser MP, Gijzen AH, Brombacher PJ.
    Am J Clin Oncol; 1988 Dec; 11 Suppl 2():S65-7. PubMed ID: 2468276
    [Abstract] [Full Text] [Related]

  • 19. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S, Skaarland E, Halvorsen OJ, Stensland E, Farstad M.
    Tidsskr Nor Laegeforen; 1990 Sep 30; 110(23):2990-3. PubMed ID: 1700496
    [Abstract] [Full Text] [Related]

  • 20. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT, Tuttle SE, Strobel SL, Gandhi L.
    J Surg Oncol; 1985 Aug 30; 29(4):265-8. PubMed ID: 2417056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.